Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00719446 · ClinicalTrials.gov registry record
Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 922
- Enrollment target
NCT00719446: Completed study, sponsored by Johns Hopkins University.
NCT00719446 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 922 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00719446 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 922 participants
- Enrollment target
Study Summary
Acute lung injury (ALI) is a severe lung condition that causes respiratory failure. The ARDS Network (ARDSNet) is a National Heart, Lung, and Blood Institute-sponsored network that is focused on improving treatments for people with ALI and a similar condition called acute respiratory distress syndrome (ARDS). This study will evaluate participants who were enrolled in one of three ARDSNet studies to examine how the treatments carried out in the prior studies affect participants' long-term health outcomes and quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 922 participants |
| Start Date | 2007-10 |
| Est. Completion | 2014-10 |
What the finished NCT00719446 record still lists
NCT00719446 is an observational study that tracks outcomes without assigning an intervention. The registered 922 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00719446 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00719446 about?
NCT00719446 is a clinical study titled "Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials". Acute lung injury (ALI) is a severe lung condition that causes respiratory failure. The ARDS Network (ARDSNet) is a National Heart, Lung, and Blood Institute-sponsored network that is focused on improving treatments for people with ALI and a similar condition called acute respiratory distress syndro...
What is the current status of trial NCT00719446?
This trial is currently completed. The enrollment target is 922 participants. The study started on 2007-10. Estimated completion is 2014-10.
Who is sponsoring clinical trial NCT00719446?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07151001 · 922 participants
Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy
- NCT04692493 · 924 participants · Phase 3
Ra-pro Pragmatic Trial
- NCT05656807 · 924 participants · NA
Evaluation of Child Care Staff Weight Management Program
- NCT06082453 · 924 participants · NA
Modernizing Perinatal Syphilis Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia